New relationships with Labcorp and Comcast NBCUniversal's Forecast Labs bolster Outcomes4Me's mission to democratize access to cancer care and improve health outcomes for all patients living with cancer

与Labcorp和Comcast NBCulsal的预测实验室的新关系支持成果4Me的使命是使所有癌症患者的癌症护理民主化并改善健康结果

BOSTON, Sept. 19, 2023 /PRNewswire/ -- Outcomes4Me Inc., the developer of the first direct-to-patient, personalized and evidence-based cancer navigation platform, announced today it has entered into two innovative collaborations and investment structures, which together combine artificial intelligence (AI) technology, treatment awareness and education, diagnostic testing access and mass media to help more patients with cancer connect with the latest treatment innovation relevant to their specific diagnosis..

第一个直接面向患者，个性化和基于证据的癌症导航平台的开发人员BOSTON，2023年9月19日/PRNewswire/-Outcomes4Me Inc.今天宣布，它已经进入两个创新的合作和投资结构，将人工智能（AI）技术，治疗意识和教育，诊断测试访问和大众媒体，以帮助更多的癌症患者与最新的治疗创新相关的具体诊断。。

Labcorp: Through an equity investment and collaboration agreement with Labcorp, a global leader of innovative and comprehensive laboratory services, Outcomes4Me is supercharging its efforts to improve patient outcomes by disseminating novel precision oncology treatment options through information about and access to specialty biomarker testing, including comprehensive genomic profiling, offered by Labcorp.

Labcorp：通过与全球创新和全面实验室服务领导者Labcorp的股权投资和合作协议，Outcomes4Me正在通过有关专业生物标志物测试的信息和获取途径传播新颖的精确肿瘤学治疗方案，从而加强其改善患者预后的努力，包括全面的基因组分析，由Labcorp提供。

The results of such tests can provide personalized insights to help guide a cancer patient's treatment plan. As part of this collaboration, Labcorp will also provide Outcomes4Me with marketing services, including point-of-care promotion and marketing services at select Labcorp patient service centers and locations..

这些测试的结果可以提供个性化的见解，以帮助指导癌症患者的治疗计划。作为此次合作的一部分，Labcorp还将为成果4ME提供营销服务，包括在选定的Labcorp患者服务中心和地点提供即时促销和营销服务。。

Forecast Labs: Outcomes4Me and Forecast Labs, a division of Comcast NBCUniversal, have entered into an earned equity investment arrangement to provide access to performance-based TV advertising to accelerate patient acquisition for Outcomes4Me. With a presence in more than 60 geographic markets and multi-device, multi-platform coverage across 170 networks, this collaboration will help ensure that every cancer patient–no matter who they are or where they receive their care–can access free resources and the clinical guidance they need to empower them to take a proactive approach to their care, based upon the latest science..

预测实验室：Outcomes4Me和预测实验室是Comcast NBCulsal的一个分公司，已签订了获得股权投资安排，以提供基于绩效的电视广告服务，以加速患者对结果的收购4ME。通过在60多个地理市场和170个网络中的多设备，多平台覆盖，这项合作将有助于确保每位癌症患者-无论他们在何处或在何处接受他们的护理-都可以获得免费资源和基于最新科学，他们需要临床指导，以使他们能够采取积极主动的方法进行护理。。

'This is an important and significant time in our company history,' said Maya R. Said, Sc.D., Founder and CEO of Outcomes4Me. 'Innovation is useless if it does not reach patients, and our data shows that more than a third of patients diagnosed with cancer in the United States do not have access to the latest treatments and this disparity is increasing as we move into the world of precision oncology.

“这是我们公司历史上一个重要而重要的时刻，”Maya R.said，Sc.D.，Outcomes4Me的创始人兼首席执行官说如果没有到达患者，创新就毫无用处，我们的数据显示，美国超过三分之一的被诊断患有癌症的患者无法获得最新的治疗方法，而且随着我们进入精确肿瘤学领域，这种差距正在增加。

With more than 150,000 cancer-patient members already using our platform, I am incredibly proud that we are bringing together the power of our technology with the reach and influence of the world's largest diagnostic company and the world's largest media company to further build our community and take a major step forward in our goal to democratize healthcare and improve outcomes.'.

有超过150000名癌症患者已经在使用我们的平台，我感到非常自豪的是，我们正在将我们的技术力量与世界上最大的诊断公司和世界上最大的媒体公司的影响力和影响力结合在一起，以进一步建立我们的社区并采取行动朝着我们实现医疗民主化和改善成果的目标迈出了重要一步。

'We can only deliver on the promise of precision medicine if patients have access to advanced diagnostic testing,' said Maggie Rougier-Chapman, Labcorp's VP of Marketing, Pharma & Therapeutic Areas. 'Through our collaboration with Outcomes4Me, we are able to expand access to guideline-driven biomarker testing options and provide personalized insights and resources that can lead to more targeted treatment plans and improved health outcomes.'.

Labcorp营销，制药和治疗领域副总裁Maggie Rougier Chapman说：“只有在患者能够获得先进的诊断测试的情况下，我们才能实现精准医学的承诺。”通过我们与Outcomes4Me的合作，我们能够扩大对指南驱动的生物标志物测试选项的访问，并提供个性化的见解和资源，从而可以制定更有针对性的治疗计划并改善健康结果。

'Outcomes4Me is playing a vital role in an incredibly complex healthcare ecosystem by helping cancer patients to not only navigate their care but also to make science-based, informed care decisions,' said Arjun Kapur, Managing Director at Forecast Labs. 'More patients need to know that they too can play a more active role in managing their cancer care, and we are looking forward to helping Outcomes4Me reach the appropriate cancer patient population via TV advertising.

“结果4Me在一个令人难以置信的复杂医疗保健生态系统中发挥着至关重要的作用，它不仅帮助癌症患者导航他们的护理，而且还帮助做出基于科学，知情的护理决策，”预测实验室总经理Arjun Kapur说更多患者需要知道他们也可以在管理癌症护理方面发挥更积极的作用，我们期待通过电视广告帮助结果4达到适当的癌症患者人群。

We are excited to have Outcomes4Me as our first oncology-focused portfolio company.'.

作为我们第一个以肿瘤学为重点的投资组合公司，我们很高兴能够取得成果。

Outcomes4Me is the first and only direct-to-patient platform that integrates with the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) and makes them patient-facing and personalized. Using AI and machine learning, Outcomes4Me gathers the FDA-approved treatment recommendations from the NCCN Guidelines®, written by and for oncologists at the world's top cancer centers, as well as clinical trials live from ClinicalTrials.gov, and translates the information into easy-to-understand, actionable guidance for patients..

Outcomes4Me是第一个也是唯一一个与NCCN肿瘤临床实践指南（NCCNGuidelines®）相结合的直接面向患者的平台，使其面向患者并个性化。使用AI和机器学习，Outcomes4Me从NCCN Guidelines®收集FDA批准的治疗建议，由世界顶级癌症中心的肿瘤学家撰写，以及ClinicalTrials.gov的临床试验，并将信息转化为易于理解，为患者提供可行的指导。。

The Outcomes4Me app is available free to patients for download on iOS and Android. After patients download the app and answer a few questions about their health history, they can immediately gain access to personalized treatment options, genetic and genomic testing opportunities, symptom tracking and management, the latest innovation and clinical trials and health records they can understand..

Outcomes4Me应用程序可供患者免费在iOS和Android上下载。患者下载该应用程序并回答有关其健康史的一些问题后，他们可以立即获得个性化治疗方案，基因和基因组测试机会，症状跟踪和管理，他们可以了解的最新创新以及临床试验和健康记录。。

About Outcomes4Me Outcomes4Me is an AI-driven patient empowerment platform that helps cancer patients take a proactive approach to their care, gaining access to personalized, evidence-based treatment options and information. The company is on a mission to democratize healthcare by providing real-time, evidence-based clinical information to cancer patients, ensuring they can effectively navigate through their disease and improve their outcomes.

关于结果4Me结果4Me是一个AI驱动的患者授权平台，可帮助癌症患者积极主动地接受治疗，获得个性化，基于证据的治疗方案和信息。该公司正致力于通过向癌症患者提供实时，基于证据的临床信息来使医疗保健民主化，确保他们能够有效地浏览疾病并改善其结果。

In doing so, Outcomes4Me is working to promote health equity by generating deeper insights that improve care, and accelerating research and access to innovation. Based in Boston, Massachusetts, Outcomes4Me is a woman-led company of seasoned healthcare, oncology, pharmaceutical, consumer and technology veterans.

在这样做的过程中，成果4Me正在努力通过产生更深入的见解来改善医疗保健，加速研究和获得创新，从而促进健康公平。总部设在马萨诸塞州波士顿，Outcomes4Me是一家由经验丰富的医疗保健，肿瘤学，制药，消费者和技术退伍军人组成的女性主导公司。

For more information, visit www.outcomes4me.com..

欲了解更多信息，请访问www.outcomes4me.com。。

SOURCE Outcomes4Me Inc.

SOURCE Outcomes4Me Inc。